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Abstract
Importance: Diabetes is a growing public health threat. One in eleven individuals have diabetes
and one in three individuals have prediabetes. Without intervention, 15-30% of individuals with
prediabetes will develop diabetes within five years. The National Diabetes Prevention Program
(DPP) led by the Centers for Disease Control and Prevention (CDC) is proven to prevent or
delay the development of diabetes in individuals with prediabetes.
Objective: A continuing medical education (CME) activity was created to increase physician
awareness of and referral to the DPP. The goal was to promote the DPP among first-line
treatments for prediabetes.
Methods: The types and requirements of different CME activities were examined. An AMA
PRA Category 1 CreditTM online enduring materials format CME was chosen as the most
effective and convenient activity to target primary care physicians. One CME credit was sought
to maximize incentive for and ease of the activity. Fellow DPP stakeholders tested the activity
and gave feedback.
Results: The CME activity included reading material highlighting awareness of prediabetes and
the DPP followed by a ten question assessment. Stakeholders took approximately thirty minutes
to complete the CME activity. A 0.5 credit AMA PRA Category 1 CreditTM online enduring
materials format CME activity was established and approved by the local CME provider.
Conclusions: The DPP CME activity was designed with simplicity to maximize dissemination
among primary care physicians. The burden of diabetes can be reduced for healthier
communities with physician referral of patients with prediabetes to DPPs.
Keywords: healthy eating, physical activity, exercise, lifestyle, intervention, quality
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Increasing Physician Awareness of and Referral to the National Diabetes Prevention
Program (DPP) using Continuing Medical Education (CME)
Diabetes is a public health threat. According to the Centers for Disease Control and
Prevention (CDC) (see Appendix A for a list of abbreviations), almost two million adults are
diagnosed with type 2 diabetes mellitus (T2DM) each year. The number of adults with T2DM
quadrupled from 5.5 million to 21.3 million between 1980 and 2012. In 2014, 29.1 million
adults (9.3% of the population) had T2DM (Centers for Disease Control and Prevention [CDC],
2015a). Regional disparities are profound. For example, 10.5% of Ohio adults and 12.8% of
Montgomery County adults had T2DM in 2013 (CDC, 2015d; CDC, 2015e). The extent of
T2DM both nationally and locally place it among the top conditions of public health concern.
Prediabetes is a silent precursor of T2DM. Only 10% of individuals with prediabetes are
aware of their condition. In 2012, 86 million adults had prediabetes. About 15-30% of
individuals with prediabetes will progress to T2DM within five years without intervention. The
projections are sobering. By 2025, one in five individuals could have diabetes if the trend
continues (CDC, 2015a). An effective and widespread intervention is critically needed.
The National Diabetes Prevention Program (DPP) is an evidence-based lifestyle change
program for preventing T2DM (CDC, 2015b). In 2010, the United States Congress established
the National DPP as part of the Patient Protection and Affordable Care Act (ACA) (2010) and
authorized the CDC to lead the program (National Association of Chronic Disease Directors,
2015). The CDC DPP is based on the National Institutes of Health’s study in 2002 (CDC,
2015c) and shows long-lasting results even after fifteen years (Bray et al., 2015). The goal is to
help participants lose 5-7% of their body weight throughout a year-long course. Trained coaches
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help participants make real lifestyle changes by including healthy eating and physical activity in
their daily lives, while also teaching problem-solving and coping skills (CDC, 2015b).
The DPP brings together the community. Public and private partnerships are facilitated to
address T2DM prevention. Healthcare providers represent an important stakeholder in the
partnership, but few participants are currently recruited into the program from their providers
(Blackwell et al., 2011). Primary care needs to be made aware of the DPP and local programs
(Rattay & Rosenthal, 2014). Training opportunities most convenient to and preferred by primary
care physicians should be explored.
Continuing medical education, commonly referred to as CME, is a fitting resource to
expand awareness of the DPP to physicians (American Medical Association [AMA], 2015).
Because physicians are required to obtain CME hours to maintain licensure and accreditation, a
DPP CME topic could reach a large number of physicians to expand knowledge and improve
care (Accreditation Council for Continuing Medical Education [ACCME], 2012b). It is hoped
that increased physician awareness of and referrals to the DPP can bring further attention to
prediabetes and help reverse the diabetes epidemic.
Purpose Statement
The purpose was to create a suitable and convenient CME activity to increase physician
awareness of and referral to the DPP for patients with prediabetes. The goal was to promote the
DPP among first-line treatments for prediabetes.
Literature Review
Overview of Diabetes Mellitus
Diabetes mellitus. Diabetes mellitus (“diabetes”) is a group of diseases categorized by
high blood glucose. The underlying cause is either insufficient or inactive insulin. Insulin is a
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hormone produced by beta cells of the pancreas and signals the body to absorb glucose. Without
sufficient or active insulin, glucose accumulates in the blood. Uncontrolled diabetes is,
therefore, harmful and leads to serious health complications, including death. In the United
States, diabetes is the leading cause of kidney failure, adult blindness, and non-traumatic lowerlimb amputations, and is the seventh leading cause of death. Five types span the spectrum of
diabetes: type 1 diabetes, type 2 diabetes, gestational diabetes, prediabetes, and other (CDC,
2015a).
Type 1 diabetes mellitus. Type 1 diabetes mellitus (T1DM), previously known as juvenile
diabetes, accounts for 5% of diabetes in the United States. T1DM is an autoimmune disease
characterized by destruction of pancreatic beta cells. Without pancreatic beta cells, the body is
unable to produce insulin and individuals must take replacement insulin. Children are most
commonly affected, but T1DM can occur at any age (CDC, 2015a). As the disease is
autoimmune, T1DM is unpreventable and not further discussed here.
Type 2 diabetes mellitus. Type 2 diabetes mellitus (T2DM), previously known as adultonset diabetes, accounts for 90-95% of diabetes in the United States. T2DM is a multifactorial
disease characterized by insulin resistance. Resistance occurs when the body no longer responds
appropriately to insulin and the pancreas can no longer produce enough insulin. Risk factors
include an age of 45 years or older, non-European ancestry, overweight, lack of exercise,
hypertension, family history of diabetes, and history of gestational diabetes. Treatment options
include lifestyle changes, medications, and insulins (CDC, 2015a). As the disease is largely
influenced by lifestyle, T2DM is preventable.
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Gestational diabetes mellitus. Gestational diabetes mellitus (GDM) is a condition of
glucose intolerance during the second or third trimester of pregnancy. A pre-existing or new
diagnosis of T2DM during the first trimester of pregnancy is considered T2DM and not GDM.
For the mother, GDM increases the risk for recurrence in later pregnancies and
development of T2DM in her lifetime. Risk factors and treatment are similar to T2DM (CDC,
2011). In addition to risk for the mother, the child is at increased risk for birth defects, stillbirth,
and future development of T2DM (American Diabetes Association [ADA], 2015). As the
disease is largely influenced by lifestyle, GDM is preventable.
Prediabetes. Prediabetes, also known as impaired fasting glucose, is a condition of glucose
intolerance. In prediabetes, blood glucose levels are higher than normal but not high enough to
be diagnosed as T2DM. Prediabetes, similar to GDM, increases the risk for development of
T2DM. Additionally, the risk for heart disease and stroke risk are increased (CDC, 2015a).
Treatment includes lifestyle changes (CDC, 2015b). As the disease is largely influenced by
lifestyle, prediabetes is preventable.
Other. Other types of diabetes account for 1-5% of diabetes in the United States.
Examples include high glucose levels secondary to genetic conditions, surgeries, medications,
infections, illnesses, and pancreatic diseases (CDC, 2015a). As the disease is secondary, other
types of diabetes are considered unpreventable and not further discussed here.
Diagnosis. Diabetes can be diagnosed (Figure 1) using multiple methods: symptoms,
hemoglobin A1c (A1c), fasting plasma glucose (FPG) and oral glucose tolerance test (OGTT).
Symptoms (e.g., increased urination, thirst and hunger) and random plasma glucose at 200 mg/dl
or greater are diagnostic. A1c measures the average plasma glucose over the past three months
and is diagnostic at 6.5% or greater. FPG measures the current plasma glucose and is diagnostic
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at 126 mg/dl or greater. OGTT (75 g) measures the current plasma glucose and is diagnostic at
200 mg/dl or greater two-hours post-prandial (PP). For comparison, normal values are less than
5.7% for A1c, less than 100 mg/dl for FPG, and less than 140 mg/dl for OGTT. GDM, however,
is diagnosed at 24-28 weeks of gestation using OGTT either at 92 mg/dl or greater fasting, 180
mg/dl or greater one-hour PP, or 153 mg/dl or greater two-hour PP; a two-step strategy using a
screening test is also available (ADA, 2015).

Figure 1. Diagnosis of prediabetes and type 2 diabetes mellitus.
Source: ADA, 2016
Type 2 Diabetes Mellitus and Precursors
Type 2 diabetes mellitus. T2DM is a preventable disease. The etiology and pathogenesis,
epidemiology, and cost will be summarized here.
Etiology and pathogenesis. T2DM is a condition of insulin resistance in which insulin
does not behave normally. In the condition, insulin has a reduced action on cells and the
pancreas can no longer produce enough insulin to compensate. Skeletal muscle, adipose tissue,
and liver cells are predominately affected in the pathogenesis. Notably, skeletal muscle
resistance contributes to the beginning stages of impaired glucose tolerance due to metabolic
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dysfunction (Henriksen, Diamond-Stanic, & Marchionne, 2011). Therefore, metabolism plays a
critical role in the development of T2DM.
Complex and increasingly understood metabolic pathways contribute to the manifestation
of T2DM. Oxidative stress appears to be the driving force behind the metabolic dysfunction
seen in T2DM. Stress occurs when oxidant production exceeds antioxidant activity and
correlates with the degree of insulin resistance. Oxidant overproduction is specifically
associated with mitochondrial inflammation. Inflammation is linked with characteristics of
T2DM, including hyperglycemia, advanced glycation end-products (AGEs), and dyslipidemia
(Akash, Rehman, & Chen, 2013; Cersosimo, Triplitt, Mandarino, & DeFronzo, 2000; Folli et al.,
2011; Henriksen et al., 2011; Kohlgruber & Lynch, 2015; Patel et al., 2015; Polyzos,
Kountouras, Deretzi, Zavos, & Mantzoros, 2012). An inflammatory environment is then
established. The environment has been termed “sterile inflammation” to denote the absence of a
microbial cause (Henriksen et al., 2011).
The metabolic dysfunction of T2DM is reversible. Recent research shows that exercise
(Bianchi & Ribisl, 2015; Dincer et al., 2015; Farabi, Carley, Smith, & Quinn, 2015; Peeri &
Amiri, 2015; Pittaluga et al., 2015; Vinetti et al., 2015) and healthy diet (Al-Shafei, 2014;
Kahleova et al., 2011; Madec, Corretti, Santini, Ferrannini, & Solini, 2011; Shirani, SalehiAbargouei, & Azadbakht, 2013) increase antioxidant activity and diminish oxidative stress by
inhibiting mitochondrial inflammation. Ergo, the research not only supports the current
understanding of diabetes, but also shows that it can be prevented. Insulin resistance, therefore,
causes metabolic dysfunction leading to sterile inflammation and can be reversed with diet and
exercise.
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Epidemiology. T2DM is a growing health concern in the United States. The number of
adults with T2DM quadrupled from 5.5 million in 1980 to 21.3 million in 2012. In 2014, 29.1
million adults (9.3% of the population) had T2DM. Almost two million adults are diagnosed
with T2DM each year and could lead to one-third of adults with T2DM by 2050 (CDC, 2015a).
State and county data from 2013 highlight striking distributions. In Ohio, 10.5% of adults
had T2DM (CDC, 2015e). The burden increases at the county level. In Montgomery County,
12.8% of adults had T2DM. One-fourth of Ohio counties, including Montgomery County, had a
prevalence greater than the United States median of 9.0% (CDC, 2015a; CDC, 2015d). The
extent of T2DM both nationally and locally stress the public health concern of diabetes.
The national T2DM epidemic appears to have plateaued (Figure 2) (CDC, 2015a). The
number of new diagnoses has not grown as quickly since 2009. While the overall rate decreased,
the burden fell on distinct populations. Diagnoses have increased among American Indians,
African Americans, Hispanics, Asian Americans and individuals with less than a high school
education. The racial disparities are significant. Individuals of non-European ancestry are 1.22.1 times more likely than individuals of European ancestry to have T2DM. Furthermore, half of
Hispanic men and women and half of black women are predicted to develop T2DM during their
lifetime. The tide may be changing, but now minority groups are at greater risk.
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Figure 2. Type 2 diabetes mellitus prevalence in the United States from 1980-2012.
Source: CDC, 2015a
Cost. Healthcare cost for T2DM in the United States is substantial. In 2009, healthcare
cost for T2DM was $11,700 per person. For comparison, healthcare cost for the average adult
was $4,600 per person. Healthcare cost is also projected to increase. The total healthcare cost
for T2DM was $148 billion in 2011 and is estimated to increase to $371 billion by 2021 (Vojta,
De Sa, Prospect, & Stevens, 2012). The economic state of the healthcare system deserves
special attention to T2DM.
Gestational diabetes mellitus. GDM is a risk factor for T2DM. The etiology and
pathogenesis, epidemiology, and cost will be summarized here.
Etiology and pathogenesis. As GDM is a risk factor for T2DM, refer above to the
discussion of etiology and pathogenesis for T2DM.
Epidemiology. GDM is a concern for pregnant women. It occurs in 2-10% of pregnancies
and increases the risk for recurrence in future pregnancies and progression to T2DM in a
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woman’s lifetime. Among women with GDM, T2DM occurs in 5-10% of women immediately
after pregnancy and in 35-60% of women within ten years of their GDM diagnosis (CDC, 2011).
The obesity and diabetes epidemics are increasing the number of GDM cases and putting
mothers and children at risk.
Cost. GDM places a significant toll on the healthcare system in the United States. In
2012, total cost for treating GDM was $1,290 million and the average cost per person was
$5,800 (Dall et al., 2014). While GDM is often overlooked when discussing T2DM, it has a
large economic impact.
Prediabetes. Prediabetes is a risk factor for T2DM. The etiology and pathogenesis,
epidemiology, and cost will be summarized here.
Etiology and pathogenesis. As prediabetes is a risk factor for T2DM, refer above to the
discussion of etiology and pathogenesis for T2DM.
Epidemiology. Prediabetes is a silent threat to public health. In 2012, 86 million adults
had prediabetes. About 15-30% of individuals with prediabetes will develop T2DM within five
years without intervention. However, 90% of adults with prediabetes are unaware (CDC,
2015a). Both professional and public awareness are needed to address prediabetes.
Cost. Healthcare cost for prediabetes in the United States is enormous. From 2007 to
2011, cost for prediabetes treatment increased from $27 billion to $38 billion. Cost is estimated
to increase to $93 billion by 2021 (Vojta et al., 2012). The current healthcare system is already
scrambling to meet the needs of adults with T2DM and may struggle to cover the increasing
number of adults who may develop T2DM.
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National Diabetes Prevention Program (DPP)
The National DPP aims to reduce the burden of T2DM by preventing or delaying the
progression to T2DM among individuals with prediabetes. In 2010, Congress passed the
National DPP as part of the ACA (2010) and authorized the CDC to lead the program (National
Association of Chronic Disease Directors, 2015). The CDC DPP curriculum is based on the
National Institutes of Health’s clinical trial published in the February 7, 2002 issue of the The
New England Journal of Medicine (Knowler et al., 2002). Subsequent studies determined the
best recruitment strategies based on demographic factors (CDC, 2015c). A significant amount of
time and research has been invested in the DPP.
The DPP is an evidence-based lifestyle change program designed to prevent T2DM. It is a
year-long program during which participants meet weekly for the first six months and then
monthly for the remaining six months. A trained lifestyle coach uses a CDC-approved
curriculum and guides a small group of participants through the program. Coaches help
participants make lifestyle changes by including healthy eating and physical activity in their
daily lives. To overcome lifestyle-change barriers, problem-solving and coping skills are also
included in the curriculum. The structured lifestyle change interventions incorporated in the
DPP help participants lose 5-7% of their body weight and reduce the risk of developing T2DM
by 58% (CDC, 2015b).
The literature is filled with positive outcomes from the DPP due to normal glucose
regulation. T2DM incidence and microvascular complications were lowest in the lifestyle group
compared to drug treatment, most commonly metformin, and placebo groups (Bray et al., 2015).
Program results are also long-lasting. After fifteen years, T2DM development was reduced by
27% in the lifestyle group and 18% in the metformin group compared with the placebo group
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(Bray et al., 2015). Notably, two-year weight loss was the strongest predictor of T2DM risk
reduction and cardiometabolic improvement among participants (Delahanty et al., 2014). Even
transient reversion to normal glucose levels was associated with a significantly reduced risk of
T2DM (Perreault et al., 2012). Clinically, FPG remains the best predictor of T2DM
development (Maruthur et al., 2013; Sussman, Kent, Nelson, & Hayward, 2015). The DPP not
only prevents T2DM, but is also long-lasting.
The DPP encourages stakeholder collaboration. Community organizations, healthcare
organizations, faith-based organizations, government agencies, employers, and private insurers
are brought together to achieve a greater impact on T2DM prevention. Healthcare providers are
an important stakeholder in program support and referrals. In one study, however, only 2% of
participants were recruited into the program from providers (Blackwell et al., 2011).
Indubitably, provider referrals can be and need to be significantly improved.
The lack of referrals from the healthcare community is perplexing. Broad integration in
the community would be expected since the initial clinical trial in 2002. However, Vojta,
Koehler, Longjohn, Lever, and Caputo (2013) posit that new treatments are developed much
faster than can be incorporated into healthcare. Sustainable linkages between primary care and
community resources can address the problem. For example, electronic health records can
prompt, flag, and remind providers to screen for and follow-up on patients at high risk for
T2DM. A single keystroke can refer patients diagnosed with prediabetes to DPP classes.
Emails, phone calls, and post cards can remind patients to attend DPP classes. Periodic reports
from DPP classes can also be sent to providers to track patient attendance and progress. Finally,
regular provider follow-ups can assess clinical effectiveness, reinforce learned skills, and

DPP AWARENESS AND REFERRAL USING CME

16

encourage continued progress (Rattay & Rosenthal, 2014). The gap between providers and
communities needs to be closed.
Healthcare provider and community resource linkages are being developed. For example,
the American Medical Association (AMA) has committed to prevent T2DM. Resources have
been created and offered to primary care offices to help physicians learn about the DPP and refer
patients with prediabetes to DPP classes. Ultimately, primary care needs to be made aware of
the DPP and local programs to maximize the benefit to communities (Rattay & Rosenthal, 2014).
Training opportunities most convenient to and preferred by primary care physicians should be
explored.
Continuing Medical Education
Continuing medical education, commonly referred to as CME, contributes to continued
physician competency after formal training is complete. Physicians are trained and accredited
through multiple steps. In the United States, initial competency is evaluated during four years of
medical school and then three-to-five years of residency training. CME thereafter establishes
competency based on standards developed by various medical boards (ACCME, 2012b).
The Accreditation Council for Continuing Medical Education (ACCME) establishes CME
standards in the United States. The mission of the ACCME is to identify, develop, and promote
quality CME standards to improve physician performance. The ACCME is an independent,
nonprofit organization that uses evidence-based content without commercial bias. The ACCME
has partnered with numerous federal agencies and medical associations, such as the CDC and
AMA (ACCME, 2012a). The AMA Physician’s Recognition Award (PRA) defines Category 1
and 2 credits. Category 1 credits are given for the acquisition of new knowledge and skills,
including attending live educational events, learning new clinical procedures, and reviewing
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journal manuscripts. Category 2 credits are given for using current knowledge and skills,
including peer consultations, group discussions, and medical writing (AMA, 2010). CME
facilitates lifelong learning in the rapidly changing field of healthcare to improve patient care.
Medical licensure boards determine CME requirements. Each state determines the number
of CME hours required to maintain licensure and local organizations serve as CME providers.
For example, the State Medical Board of Ohio (n.d.) requires that physicians complete 100 CME
hours (40 Category 1 hours and 60 Category 2 hours) every two years; Wright State University
(WSU) Boonshoft School of Medicine (BSOM) serves physicians of Southwest Ohio (Wright
State University Boonshoft School of Medicine [WSU BSOM], 2015). Each medical association
also determines the number of CME hours required to maintain accreditation. For example, the
American Academy of Family Physicians (2015) requires 150 CME hours every three years.
CME is a fitting resource to expand the DPP to physicians. Prediabetes screening and DPP
referrals are new guidelines and physicians need to learn about the program. Because physicians
are required to obtain CME hours to maintain licensure and accreditation, a DPP CME activity
could reach a large number of physicians to expand knowledge and improve care. It is hoped
that increased physician awareness of and referrals to the DPP can bring further attention to
prediabetes and help reverse the diabetes epidemic.
Methods
Overview
A CME activity was determined to be the best strategy to target physicians. The goal was
to teach physicians new knowledge about the DPP using a web-based activity. Therefore, the
credit and format were structured according to AMA PRA Category 1 CreditTM and enduring
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materials requirements, respectively. The CME activity was submitted for approval to WSU
BSOM, an accredited CME provider.
AMA PRA Category 1 CreditTM Requirements
Credit requirements. AMA PRA Category 1 CreditTM is designated for the acquisition of
new knowledge. The DPP CME activity taught a new resource and, therefore, applied to
Category 1 Credit. Ten core requirements are established for Category 1 Credit (Figure 3)
(AMA, 2010). In reference to the first core requirement, the AMA defines CME as follows:
CME consists of educational activities which serve to maintain, develop, or increase the
knowledge, skills, and professional performance and relationships that a physician uses
to provide services for patients, the public, or the profession. The content of CME is the
body of knowledge and skills generally recognized and accepted by the profession as
within the basic medical sciences, the discipline of clinical medicine and the provision of
health care to the public (AMA, 2010, p. 2).
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Objective

1

Conform to the AMA’s definition of CME.

2

Address demonstrated educational needs.

3

Communicate to prospective participants a clearly identified educational purpose and/or
objectives in advance of participation in the activity.

4

Be designed using AMA approved learning formats and learning methodologies
appropriate to the activity’s educational purpose and/or objectives; credit must be based
on AMA guidelines for the type of learning format used.

5

Present content appropriate in depth and scope for the intended physician audience.

6

Be planned in accordance with the relevant CEJA opinions and the ACCME Standards for
Commercial Support, and be nonpromotional in nature.

7

Evaluate the effectiveness in achieving its educational purpose and/or objectives.

8

Document credits claimed by physicians for a minimum of six years.

9

Be certified for AMA PRA Category 1 CreditTM in advance of the activity; i.e. an activity
may not be retroactively approved for credit.

10

Include the AMA Credit Designation Statement in any activity materials that reference
CME credit with the exception of “save the date” or similar notices.

Figure 3. AMA PRA Category 1 CreditTM core requirements.
Source: AMA, 2010, p. 4
Format requirements. AMA PRA Category 1 CreditTM offers seven learning formats:
live activities, enduring materials, journal publication, test item writing, journal review,
performance improvement, and Internet point-of-care learning. Enduring materials format is a
CME activity that endures over a specified time, unlike live educational events. Examples of
enduring materials include print, audio, video, and Internet materials. The DPP CME activity in
this project was web-based and, therefore, applied to enduring materials. Five requirements are
established for the enduring materials format (Figure 4). The amount of credit is determined by
a good faith estimate of the expected amount of time required to complete the activity
established by the CME provider. Physicians may only claim credit for the actual time spent on
the activity, but no more than established by the CME provider. Credit is designated in 15
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minute or 0.25 credit increments, rounded to the nearest quarter hour, and awarded to physicians
who meet minimum performance established by the CME provider (AMA, 2010).
Requirement

Objective

1

Meet all AMA core requirements for certifying an activity.

2

Provide clear instructions to the learner on how to successfully complete the activity.

3

Provide an assessment of the learner that measures achievement of the educational purpose
and/or objective(s) of the activity with an established minimum performance level; examples
include, but are not limited to, patient-management case studies, a post-test, and/or application
of new concepts in response to simulated problems.

4

Communicate to the participants the minimum performance level that must be demonstrated in
the assessment in order to successfully complete the activity for AMA PRA Category 1 CreditTM.

5

Provide access to appropriate bibliographic sources to allow for further study.

Figure 4. AMA enduring materials format requirements.
Source: AMA, 2010, p. 5
DPP CME activity. The DPP CME activity was developed from AMA PRA Category 1
CreditTM and enduring materials format requirements with information provided by CDC and
peer-reviewed journals indexed on PubMed. The CME activity reading material was outlined
into preface, prediabetes, DPP, and postface sections (Table 1) with primary care physicians as
the target audience. In addition to the reading material, a five-minute CDC-sponsored video
highlighted a DPP session as individuals described their experience of being diagnosed with
prediabetes and participating in the program. The CME activity was designed to take one hour
to complete, including reading the materials, watching the video, and completing the assessment.
One credit was chosen to maximize the CME activity’s reach through ease and incentive to
complete the activity.
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Table 1
Continuing Medical Education Reading Material Outline for DPP Activity
Section

Components

Preface

About
Objectives
Abbreviations
Introduction

Prediabetes

Overview
Epidemiology
Cost
Diagnosis

Diabetes Prevention Program

About
Referral
Resources
Risk Assessment Quiz
DPP Search Locator
Video

Postface

Summary
References

The CME activity was offered on the online learning gateway at WSU called Pilot
(https://pilot.wright.edu) (see Appendix B for registration instructions). Pilot allowed secure
enrollments, storable files, deliverable assessments, and anonymous surveys. The assessment
could be completed with unlimited attempts to achieve the minimum passing score. A PDF
certificate was then unlocked only after successfully passing the assessment.
Public health graduate students and faculty tested the CME activity before submission to
the CME provider. The average time to complete the CME activity and ease of navigation
through the Pilot webpage were determined. Feedback, such as content, opinions, and
suggestions, were encouraged.

DPP AWARENESS AND REFERRAL USING CME

22

Results
Overview
A one-hour AMA PRA Category 1 CreditTM enduring materials format CME activity was
developed for the DPP and offered on Pilot. The goal was to increase physician awareness of
and referral to the DPP for patients with prediabetes. The CME activity included a twelve-page
reading material with a five-minute CDC-sponsored video and references (Appendix C), a ten
question assessment with answer explanations and references (Appendix D), and a nine question
survey (Appendix E). The CME activity was submitted to WSU BSOM for approval.
Trial
First, three first-year master of public health (MPH) students, three third-year medical
students in the dual degree program (MD/MPH), and one physician faculty member tested the
CME activity reading materials and assessment. Thirty minutes was the average time to
complete the CME activity and students commented on a well-designed, informative, and
straightforward activity. Second, stakeholders tested the CME activity on Pilot. Stakeholders
also took approximately thirty minutes to complete the CME activity and commented on
appropriate content and easy interface. The CME activity was then redefined for 0.5 credit.
Submission
Next, an application was completed for submission to WSU BSOM. Activity details,
financial reports, and conflict of interest forms were completed. The WSU BSOM Center for
Global Health paid the $300 application fee. Approval (Appendix F) was granted by the CME
provider before dissemination.
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Dissemination
Physicians were recruited through advertisements (Appendix G), emails, and word of
mouth. The CME activity can be accessed by visiting Pilot (https://www.pilot.wright.edu),
clicking External Registration at the bottom of the page, and registering for the Diabetes
Prevention Program CME. Activity materials are downloadable and CME credit is available
through 31 March 2019.
Discussion
Audience
A CME activity was designed for physicians to increase awareness of and referral to the
DPP. Currently, a significant minority of participants in DPPs are referred from their physicians.
The CDC began leading the DPP in 2010 and is urging nationwide dissemination. To recruit
participants into the program, multiple stakeholders are brought together to prevent or reduce the
burden of diabetes.
Physicians are unique stakeholders. They have strong relationships with their patients,
can readily screen for prediabetes, and can diagnose prediabetes. Physician recommendation can
add trust and value to the program and increase patient willingness to join the program.
Physicians can also regularly follow up on progress made in the program. The goal is to
establish the DPP, rather than medication alone, among first-line treatment options for
prediabetes. Medication, specifically metformin, alone is less effective than the DPP at
preventing or reducing the progression to diabetes among individuals with prediabetes and
should no longer be the only treatment on which physicians rely.
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Design
The CME activity was designed with ease and incentive to maximize physician reach. A
one-credit online CME activity was, therefore, created. However, trial activities revealed that
the CME activity could be completed in thirty minutes and it was redefined for 0.5 credits. The
CME activity included a twelve-page reading material with a five-minute CDC-sponsored video
and references plus a ten-question assessment with answer explanations and references that
physicians can take anytime, anywhere. The intent was that greater convenience would lead to
increased interest and completion among physicians.
Limitations
Difficulty. Because the CME activity was based on materials created for the general
public, physicians may find the CME activity too simplistic and become disinterested. While the
goal was to make the CME activity as easy as possible to maximize dissemination and diffusion,
physician feedback will need to be sought to ensure appropriate depth and scope.
Dissemination. Dissemination is vital to the success of the CME activity. Physicians
must be made aware of and encouraged to take the CME activity. Collaboration with community
stakeholders will be crucial to deliver the CME activity to physicians, which is beyond the scope
the project here.
Conclusions and Recommendations
The DPP CME activity was designed with ease and simplicity on Pilot to maximize
dissemination among primary care physicians. The CME activity included reading material,
video, and assessment to be completed in thirty minutes to incentivize physicians with sufficient
credit and minimal time. An application was sent to WSU BSOM for approval of the CME
activity for 0.5 AMA PRA Category 1 CreditTM as an enduring materials format. Substantial and
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long-term research supports the effectiveness and superiority of the DPP over other strategies for
the treatment of prediabetes. The goal was to include the DPP among first-line treatments for
prediabetes. To accomplish the goal of awareness of and referral to the DPP, the CME activity
designed here will be disseminated to physicians. CME providers were highly encouraged to
advertise the DPP CME activity to increase the number of physicians who complete the CME
activity. Recommendations include advertising to other healthcare and public health
professionals, such as nurses and community health workers, and, if needed, obtaining credit
approval for their respective CME providers. The burden of diabetes can be reduced for
healthier communities with physician referral to DPPs of patients at high risk for or diagnosed
with prediabetes.
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Abbreviations
A1c — Hemoglobin A1c
ACA — The Patient Protection and Affordable Care Act
ACCME — Accreditation Council for Continuing Medical Education
ADA — American Diabetes Association
AMA — American Medical Association
BSOM — Boonshoft School of Medicine
CDC — Centers for Disease Control and Prevention
CME — Continuing medical education
DPP — Diabetes Prevention Program
FPG — Fasting plasma glucose
GDM — Gestational diabetes mellitus
OGTT — Oral glucose tolerance test
PP — Post-prandial
PRA — Physician’s Recognition Award
T1DM — Type 1 diabetes mellitus
T2DM — Type 2 diabetes mellitus
WSU — Wright State University
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Appendix H
Competencies Met in CE
Tier 1 Core Public Health Competencies
Domain #1: Analytic/Assessment Skills
Identifies quantitative and qualitative data and information (e.g., vital statistics, electronic health records,
transportation patterns, unemployment rates, community input, health equity impact assessments) that can be used
for assessing the health of a community
Applies ethical principles in accessing, collecting, analyzing, using, maintaining, and disseminating data and
information
Uses information technology in accessing, collecting, analyzing, using, maintaining, and disseminating data and
information
Selects valid and reliable data
Uses quantitative and qualitative data
Describes assets and resources that can be used for improving the health of a community (e.g., Boys & Girls Clubs,
public libraries, hospitals, faith-based organizations, academic institutions, federal grants, fellowship programs)
Domain #2: Policy Development/Program Planning Skills
Contributes to development of program goals and objectives
Describes organizational strategic plan (e.g., includes measurable objectives and targets; relationship to community
health improvement plan, workforce development plan, quality improvement plan, and other plans)
Contributes to implementation of organizational strategic plan
Identifies current trends (e.g., health, fiscal, social, political, environmental) affecting the health of a community
Describes implications of policies, programs, and services
Implements policies programs, and services
Gathers information for evaluating policies, programs, and services (e.g., outputs, outcomes, processes, procedures,
return on investment)
Applies strategies for continuous quality improvement
Domain #3: Communication Skills
Communicates in writing and orally with linguistic and cultural proficiency (e.g., using age-appropriate materials,
incorporating images)
Solicits input from individuals and organizations (e.g., chambers of commerce, religious organizations, schools,
social service organizations, hospitals, government, community-based organizations, various populations served) for
improving the health of a community
Suggests approaches for disseminating public health data and information (e.g., social media, newspapers,
newsletters, journals, town hall meetings, libraries, neighborhood gatherings)
Conveys data and information to professionals and the public using a variety of approaches (e.g., reports,
presentations, email, letters)
Communicates information to influence behavior and improve health (e.g., uses social marketing methods, considers
behavioral theories such as the Health Belief Model or Stages of Change Model)
Facilitates communication among individuals, groups, and organizations
Describes the roles of governmental public health, health care, and other partners in improving the health of a
community
Domain #4: Cultural Competency Skills
n.a.
Domain #5: Community Dimensions of Practice Skills
Describes the programs and services provided by governmental and non-governmental organizations to improve the
health of a community
Recognizes relationships that are affecting health in a community (e.g., relationships among health departments,
hospitals, community health centers, primary care providers, schools, community-based organizations, and other
types of organizations)
Suggests relationships that may be needed to improve health in a community
Supports relationships that improve health in a community
Collaborates with community partners to improve health in a community (e.g., participates in committees, shares
data and information, connects people to resources)
Engages community members (e.g., focus groups, talking circles, formal meetings, key informant interviews) to
improve health in a community
Provides input for developing, implementing, evaluating, and improving policies, programs, and services
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Domain #5: Community Dimensions of Practice Skills (continued)
Uses assets and resources (e.g., Boys & Girls Clubs, public libraries, hospitals, faith-based organizations, academic
institutions, federal grants, fellowship programs) to improve health in a community
Informs the public about policies, programs, and resources that improve health in a community
Domain #6:Public Health Sciences Skills
Retrieves evidence (e.g., research findings, case reports, community surveys) from print and electronic sources (e.g.,
PubMed, Journal of Public Health Management and Practice, Morbidity and Mortality Weekly Report, The World
Health Report) to support decision making
Recognizes limitations of evidence (e.g., validity, reliability, sample size, bias, generalizability)
Describes evidence used in developing, implementing, evaluating, and improving policies, programs, and services
Suggests partnerships that may increase use of evidence in public health practice (e.g., between practice and
academic organizations, with health sciences libraries)
Domain #7: Financial Planning and Management Skills
Adheres to organizational policies and procedures
Operates programs within budget
Motivates colleagues for the purpose of achieving program and organizational goals (e.g., participating in teams,
encouraging sharing of ideas, respecting different points of view)
Uses evaluation results to improve program and organizational performance
Describes program performance standards and measures
Domain #8: Leadership and Systems Thinking Skills
Incorporates ethical standards of practice (e.g., Public Health Code of Ethics) into all interactions with individuals,
organizations, and communities
Describes public health as part of a larger inter-related system of organizations that influence the health of
populations at local, national, and global levels
Describes the ways public health, health care, and other organizations can work together or individually to impact the
health of a community
Contributes to development of a vision for a healthy community (e.g., emphasis on prevention, health equity for all,
excellence and innovation)
Describes needs for professional development (e.g., training, mentoring, peer advising, coaching)
Participates in professional development opportunities

